Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dialysate and replacement fluid composition for CRRT.

Filippo Aucella1, Salvatore Di Paolo, Loreto Gesualdo

  • 1Department of Nephrology, Dialysis and Transplantation, University of Foggia, Foggia, Italy.

Contributions to Nephrology
|April 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter study.

Journal of hypertension·2026
Same author

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Kidney international reports·2026
Same author

[Tempistica e Durata delle Visite Nefrologiche in Italia].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

"Interpreting Hemoadsorption in Septic Shock: Methodological Considerations and Dosing Implications".

Shock (Augusta, Ga.)·2026
Same author

Ketoanalogue-Supplemented Low-Protein Diet in Patients with Stage 4+ Chronic Kidney Disease in Italy: A Cost-Utility Analysis.

Nutrients·2026
Same author

The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock.

Annals of intensive care·2026

Bicarbonate-buffered replacement fluids in continuous renal replacement therapies (CRRTs) may improve acid-base status and reduce cardiovascular events compared to lactate fluids. Careful balancing of buffer and electrolyte concentrations is crucial for patient outcomes.

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Biochemistry

Background:

  • Continuous renal replacement therapies (CRRTs) are vital for managing acid-base balance in intensive care unit (ICU) patients.
  • Acid-base balance during CRRTs is significantly affected by dialysis technique and fluid administration routes.
  • The choice of buffer in replacement fluids impacts both acid-base correction and clinical outcomes.

Purpose of the Study:

  • To evaluate the impact of different buffer types in CRRT replacement fluids on acid-base status and clinical outcomes.
  • To highlight the importance of balancing buffer and electrolyte concentrations in CRRT fluids.
  • To emphasize quality control measures in CRRT fluid management.

Main Methods:

  • Comparison of lactate-buffered versus bicarbonate-buffered replacement fluids in CRRTs.

Related Experiment Videos

  • Analysis of buffer balance considering ultrafiltrate losses, replacement fluid gains, and dialysate interactions.
  • Assessment of electrolyte concentrations in dialysate and replacement fluids for physiological balance.
  • Main Results:

    • Bicarbonate-buffered fluids show potential for better acid-base correction and reduced cardiovascular events compared to lactate fluids.
    • Supraphysiological buffer concentrations may be necessary to compensate for deficits and extracorporeal losses.
    • Careful balancing of dialysate and replacement fluid buffer and electrolyte concentrations is essential.

    Conclusions:

    • Bicarbonate-buffered replacement fluids may offer superior clinical benefits over lactate-buffered fluids in CRRTs.
    • Individualized prescription and meticulous balance control of fluids are critical for effective CRRT management.
    • Quality control for sterility and physical properties of CRRT fluids is paramount.